Who owns ABVC BIOPHARMA INC?
- Ticker: ABVC
- CUSIP Number: 00091f304
Tip: Access positions for across all investors
Analyze quarterly positions in Abvc Biopharma with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Abvc Biopharma stock
Who bought or sold ABVC BIOPHARMA INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Chase Investment Counsel Corp. | 178k | $233k | 100% | Mar 2024 |
|
| Vanguard Group | 47k | $62k | 72% | Mar 2024 |
|
| Geode Capital Management | 22k | $29k | 13% | Mar 2024 |
|
| Bank of America Corporation | 4.4k | $5.8k | 100% | Mar 2024 |
|
| Tower Research Capital | 2.5k | $3.3k | -16% | Mar 2024 |
|
| Spotlight Asset Group | 100.00 | $131.000000 | 0% | Mar 2024 |
|
| Wells Fargo & Company | 48.00 | $63.000000 | 140% | Mar 2024 |
|
| Royal Bank of Canada | 37.00 | $0 | 0% | Mar 2024 |
|
Who sold out of Abvc Biopharma?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Citadel Advisors | Dec 2023 | 27k | $32k |